GW-353430

N/A

Report date: 2024/11/28 17:37:19

Base Information

Drug NameGW-353430
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionImmunoglobulin epsilon Fc receptor antagonists
TargetsImmunoglobulin epsilon Fc receptor
Therapy Area/IndicationsAsthmaRheumatic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsAsthmaRheumatic Diseases

Other Information

ATC CodeN/A
Related LinksN/A